QuidelOrtho Maintenance and Reagents
Archived on February 10, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM EST
- Posted
- January 16, 2026
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- No Set aside used
- NAICS
- 325413: In-Vitro Diagnostic Substance Manufacturing
- Agency
- Department of Health and Human ServicesCENTERS FOR DISEASE CONTROL AND PREVENTION
Notice details
- Office
- CDC OFFICE OF ACQUISITION SERVICES
- Place of performance
- Georgia, 30329
- Last updated
- Nov 4, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75D30125Q78789
- Notice ID
- a80f89919b3c42babd61fa4d52be52bc
Description
The Centers for Disease Control and Prevention (CDC), Office of Acquisition Services, intends to award a sole source, firm-fixed-price purchase order to QuidelOrtho Corporation, 9975 Summer Ridge Road, San Diego, California 92121 under the authority of FAR 13.106-1(b)(1)(i). The anticipated award is for commercial services and is valued below the Simplified Acquisition Threshold (SAT). This procurement is for urgent maintenance and OEM support services for a VITROS 3600 systems used by the Division of Viral Hepatitis Laboratory Branch at CDC, required services include:
Preventive maintenance will be performed in once a year.
The agreement should also include field application support.
All software and hardware updated must be included.
Email and phone technical support must be available through the life of the agreement during business hours, (Mon-Fri).
The service agreement will cover all repairs, replacements, and labor incur by instrument failures.
As a result, this requirement will be processed under the Simplified Acquisition Procedures of FAR Part 13. QuidelOrtho Corporation is the original equipment manufacturer (OEM) and the only known source with access to the proprietary reagents, diagnostics, and service infrastructure necessary to support the proprietary(VITROS 3600) model equipment system in accordance with manufacturer specifications. This is a combined synopsis/solicitation for commercial service prepared with additional information included in this notice. The solicitation number is 75D30126Q78789 and is issued on a Request for Quote (RFQ) form as appropriate. The combined synopsis/solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2021-07. The associated North American Industrial Classification System (NAICS) code for this procurement is 325413 with a small business size standard of 1,250 employees. The CDC intends to award a sole source firm fixed price purchase order to QuidelOrtho Corporation. This is an open market posting with only one known qualified offeror. Responses must be received no later than the deadline listed above and must reference this RFQ notice, 75D30126Q78789. This contract action is for supplies and license services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested entities may identify their interest and capability with this requirement. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Any additional information received will normally be considered for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to Gary Morgan, Contract Specialist at gmorgan1@cdc.gov by 12:00PM EST Monday, January 26, 2026. No further notice will be posted.
A determination by the Government not to compete this requirement based on responses to this notice is solely within the discretion of the Government.
LOCATION: 1600 Clifton Rd, Atlanta, GA 30329. Roybal campus, Bldg 18th 4th floor, Room 4-605
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Files (1)
- Download
RFQ 75D30126Q78789 Revised due date 1 26 2026 QuidelOrtho Corp.doc
243 KBAdded in Combined Synopsis/Solicitation version 3Posted
Lifecycle
- 1Version 1Combined Synopsis/SolicitationArchived
QuidelOrtho Maintenance and Reagents
- 3Version 3Combined Synopsis/SolicitationArchivedCurrent
QuidelOrtho Maintenance and Reagents
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Amendment 5 is being issued to re-open the solicitation and proceed with source selection activities. Reinstate Jennifer Gartzke as the point of contact. The attached SF30 contains additional information. | 74% | Solicitation | 02/15/2026 |
VA Boise, Idaho - Blood Bank Reagents Requirement | 66% | Pre-Solicitation | 10/26/2026 |
VA Boise, Idaho - Blood Bank Reagents Requirement | 66% | Pre-Solicitation | 10/26/2026 |
Boise, Idaho VAMC Transfusion Services requires red blood cell reagents that meet strict quality control and compliance standards for patient testing. These reagents are essential for safely matching donated blood products to recipients who need them for life-saving treatments—a process carried out exclusively in the Transfusion Services Department. The vendor is responsible for supplying quality control check cells as well as antibody identification panel cells to fulfill these requirements and support effective patient care. 5-year agreement. Base Year Period of Performance: 12/01/2026-11/30/2027. Four option years to follow based upon the Government's needs and discretion. Transfusion Medicine supports all major hospital departments, including Emergency, Surgery, Oncology, and Medical Units. Without a dedicated Transfusion Medicine Department, these units cannot operate effectively. Each VAMC needs its own department, as services are site-specific across the VISN. The vendor must keep track of the lot numbers and expiration dates for each reagent provided to the Boise VAMC Blood Bank. Since these reagents are made from cellular material, they expire quickly. The vendor should send the new lot number shortly before the old one expires to ensure the Blood Bank always has the necessary reagents for matching blood products. The vendor shall supply the Transfusion Service with red blood cells reagents that meet the current standards and/or regulations of the Food and Drug Administration (FDA), the College of American Pathologists (CAP), the Joint Commission (TJC), and the American Association of Blood Banks (AABB) to ensure patient safety. | 64% | Solicitation | 11/18/2026 |
***View attachments for details*** | 54% | Market Research | 11/10/2026 |
Additional Details
Solicitation Number
75D30125Q78789
Archive Date
Feb 10, 2026
Office Address
ATLANTA, GA, 30333